(Q37610143)

English

Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis

scientific article published on January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 August 2017

0 references

1 reference

Europe PubMed Central

Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis (English)

1 reference

Europe PubMed Central

21 August 2017

0 references

0 references

systematic review

1 reference

based on heuristic

inferred from title

object named as

Imis Dogan

4

0 references

Yvonne Nestoriuc

object named as

Yvonne Nestoriuc

2

0 references

Stefan G. Hofmann

object named as

Stefan G Hofmann

6

0 references

1

object named as

Winfried Rief

1 reference

Europe PubMed Central

21 August 2017

8

object named as

Jerry Avorn

1 reference

Europe PubMed Central

21 August 2017

author name string

Anna von Lilienfeld-Toal

3

1 reference

Europe PubMed Central

21 August 2017

Franziska Schreiber

5

1 reference

Europe PubMed Central

21 August 2017

Arthur J Barsky

7

1 reference

Europe PubMed Central

21 August 2017

publication date

1 January 2009

1 reference

Europe PubMed Central

21 August 2017

1 reference

Europe PubMed Central

21 August 2017

32

1 reference

Europe PubMed Central

21 August 2017

11

1 reference

Europe PubMed Central

21 August 2017

1041-1056

1 reference

Europe PubMed Central

21 August 2017

https://scigraph.springernature.com/pub.10.2165/11316580-000000000-00000

0 references

A double blind comparison of lofepramine, imipramine and placebo in patients with depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy, safety, and tolerability of sertraline in patients with late-life depression and comorbid medical illness

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoxetine versus placebo in posttraumatic stress disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of manipulating expectations through placebo and nocebo administration on gastric tachyarrhythmia and motion-induced nausea

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paroxetine versus placebo: a double-blind comparison in depressed patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paroxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Who controls the placebo? Introducing a Placebo Quality Checklist for pharmacological trials.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of adverse events associated with triptans--methods of assessment influence the results

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug-related information generates placebo and nocebo responses that modify the drug response.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endogenous opiates and the placebo effect: a meta-analytic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Escitalopram in the treatment of social anxiety disorder: randomised, placebo-controlled, flexible-dosage study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the nocebo effect during oral challenge in patients with adverse drug reactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoxetine in social phobia: a double-blind, placebo-controlled pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, placebo-controlled dose-finding study with sertraline

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placebo-associated blood pressure response and adverse effects in the treatment of hypertension: observations from a Department of Veterans Affairs Cooperative Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive-Compulsive Disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: A single-blind randomised placebo controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled-release paroxetine in the treatment of patients with social anxiety disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imipramine treatment of children with separation anxiety disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: randomised, double-blind, placebo-controlled, fixed-dose study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy of sertraline in panic disorder: combined results from two fixed-dose studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind placebo-controlled pilot study of paroxetine for specific phobia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trimipramine in physical illness with depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, placebo-controlled study of fluoxetine in depressed patients with Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pattern analysis shows beneficial effect of fluoxetine treatment in mild depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of generalized anxiety disorder with escitalopram: pooled results from double-blind, placebo-controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A placebo-controlled trial of paroxetine in the treatment of major depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cortical correlates of false expectations during pain intensity judgments--a possible manifestation of placebo/nocebo cognitions

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoxetine in depressed patients on dialysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placebo/nocebo symptom reporting in a sham herbal supplement trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind comparison of citalopram and placebo in depressed outpatients with melancholia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12- to 24-week extension phase of a multicentre, randomized, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Escitalopram in the treatment of depressed elderly patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reconsidering the role of personality in placebo effects: dispositional optimism, situational expectations, and the placebo response.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled efficacy study of fluoxetine in dysthymia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonspecific medication side effects and the nocebo phenomenon

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medication adherence and persistence as the cornerstone of effective antihypertensive therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of learning in nocebo and placebo effects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind trial of fluoxetine, 20 mg, and placebo in out-patients with DSM-III-R major depression and melancholia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoxetine for the treatment of childhood anxiety disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. The Fluoxetine Collaborative Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of low dose lofepramine in depressed elderly patients in general medical wards

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of usual antidepressant dosing regimens of fluoxetine in panic disorder: randomised, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sertraline in the treatment of panic disorder. A multi-site, double-blind, placebo-controlled, fixed-dose investigation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose fluoxetine therapy for depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clomipramine treatment of agoraphobic women. An eight-week controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of sertraline in a 12-week trial for generalized anxiety disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sertraline in obsessive-compulsive disorder: a double-blind comparison with placebo

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of posttraumatic stress disorder with amitriptyline and placebo.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A placebo-controlled, double-blind, clinical trial of paroxetine in depressed outpatients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clomipramine in obsessive-compulsive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of fluvoxamine on panic disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placebo response in studies of major depression: variable, substantial, and growing

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Oral Dose-Effect Relationship for Fluvoxamine: a Fixed-Dose Comparison Against Placebo in Depressed Outpatients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The additive impact of anxiety and a placebo on pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoxetine in children and adolescents with OCD: a placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placebo-controlled treatment trial of depression in elderly physically ill patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatization symptoms and hypochondriacal features in the general population

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cognitive-Behavior Therapy, Sertraline, and Their Combination for Children and Adolescents With Obsessive-Compulsive Disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: a comparison with self-reported symptoms. Outcomes Committee of the AIDS Clinical Trials Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adolescent depression: controlled desipramine treatment and atypical features

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sex-related differences in nortriptyline-induced side-effects among depressed patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Escitalopram and paroxetine in the treatment of generalised anxiety disorder: randomised, placebo-controlled, double-blind study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoxetine versus other types of pharmacotherapy for depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placebo and Nocebo Responses, Cortisol, and Circulating Beta-Endorphin

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sertraline in the treatment of panic disorder: a double-blind multicenter trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatization in the population: from mild bodily misperceptions to disabling symptoms.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, placebo-controlled study of paroxetine in depressed outpatients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dothiepin versus doxepin in major depression: results of a multicenter, placebo-controlled trial. Prothiaden Collaborative Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response to desipramine treatment in adolescent depression: a fixed-dose, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluvoxamine-controlled release formulation for the treatment of generalized social anxiety disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fixed-dose fluoxetine therapy for depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

When words are painful: unraveling the mechanisms of the nocebo effect

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoxetine in the acute treatment and relapse prevention of combat-related post-traumatic stress disorder: Analysis of the veteran group of a placebo-controlled, randomized clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sertraline treatment of major depression in patients with acute MI or unstable angina

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoxetine in posttraumatic stress disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paroxetine in the treatment of obsessive-compulsive disorder: randomized, double-blind, placebo-controlled study in Japanese patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoxetine in early poststroke depression: a double-blind placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sertraline treatment for generalized anxiety disorder: a randomized, double-blind, placebo-controlled study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of treating depression on quality-of-life and exercise tolerance in severe COPD.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Escitalopram in obsessive–compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antidepressant prescription for depression in general practice in The Netherlands.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind placebo-controlled study of controlled release fluvoxamine for the treatment of generalized social anxiety disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How prior experience shapes placebo analgesia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19810776

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11316580-000000000-00000

1 reference

Europe PubMed Central

21 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

21 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37610143&oldid=2151439219"